...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >Characterization of beta3-adrenoceptor-mediated relaxation in rat abdominal aorta smooth muscle.
【24h】

Characterization of beta3-adrenoceptor-mediated relaxation in rat abdominal aorta smooth muscle.

机译:在大鼠腹主动脉平滑肌中β3-肾上腺素受体介导的松弛的表征。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study was carried out to characterize beta-adrenoceptor subtypes mediating relaxation of rat abdominal aorta smooth muscle. (-)-Isoprenaline and a nonconventional beta(3)-adrenoceptor agonist, (+/-)-[4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]-1,3-dihydro-2H-be nzimidazol-2-one] hydrochloride ((+/-)-CGP12177A), induced concentration-dependent relaxation of (-)-phenylephrine (0.3 microM) preconstricted spiral preparations. Pretreatment with a combination of (+/-)-2-hydroxy-5-[2-[[2-hydroxy-3-[4-[1-methyl-4-(trifluoromethyl)-1H-imi dazol-2-yl]phenoxy]propyl]amino]ethoxy]-benzamide methanesulfonate (CGP20712A, a selective beta(1)-adrenoceptor antagonist) and (+/-)-1-[2,3-(dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino] -2-butanol hydrochloride (ICI-118,5511, a selective beta(2)-adrenoceptor antagonist) (0.1 microM for each) produced a 14-fold rightward shift of the concentration-response curve for (-)-isoprenaline; however, the relaxation in response to (+/-)-CGP12177A was unaffected by the blockade of beta(1)- and beta(2)-adrenoceptors. In the presence of CGP20712A and ICI-118,551 (0.1 microM for each), the concentration-response curves for (-)-isoprenaline and (+/-)-CGP12177A were shifted to the right by a nonselective beta(1)-, beta(2)- and beta(3)-adrenoceptor antagonist, (+/-)-bupranolol (3 and 10 microM). These results clearly suggest that beta(3)-adrenoceptors are involved in beta-adrenoceptor-mediated relaxation of rat abdominal aorta smooth muscle.
机译:进行本研究以表征介导大鼠腹主动脉平滑肌松弛的β-肾上腺素受体亚型。 (-)-异丙肾上腺素和非常规β(3)-肾上腺素受体激动剂,(+/-)-[4- [3-[(1,1-二甲基乙基)氨基] -2-羟基丙氧基] -1,3-二氢- 2H-苯并咪唑-2-酮]盐酸盐((+/-)-CGP12177A)诱导的(-)-去氧肾上腺素(0.3 microM)预缩螺旋制剂的浓度依赖性弛豫。 (+/-)-2-羟基-5- [2-[[2-羟基-3- [4- [1-甲基-4-(三氟甲基)-1H-咪唑] -2-基]组合的预处理[苯氧基]丙基]氨基]乙氧基]-苯甲酰胺甲磺酸盐(CGP20712A,选择性β(1)-肾上腺素受体拮抗剂)和(+/-)-1- [2,3-(二氢-7-甲基-1H-茚满- 4-基)氧基] -3-[(1-甲基乙基)氨基] -2-丁醇盐酸盐(ICI-118,5511,选择性β(2)-肾上腺素受体拮抗剂)(每种0.1 microM)产生14倍(-)-异丙肾上腺素浓度-响应曲线的右移;但是,响应(+/-)-CGP12177A的松弛不受β(1)-和β(2)-肾上腺素受体的阻滞作用的影响。在存在CGP20712A和ICI-118,551(各为0.1 microM)的情况下,(-)-异肾上腺素和(+/-)-CGP12177A的浓度响应曲线向右移动了非选择性beta(1)-,beta (2)-和β(3)-肾上腺素受体拮抗剂,(+/-)-丁苯丙醇(3和10 microM)。这些结果清楚地表明,β(3)-肾上腺素受体参与了β-肾上腺素受体介导的大鼠腹主动脉平滑肌的松弛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号